2CB-Ind

2C-B-Ind is a psychedelic drug of the 2C family. It was first synthesized by Alexander Shulgin. The drug is used primarily as a psychedelic and an entactogen. Its effects are considered to be similar to those of 2C-B.

History

2C-B-Ind was first synthesized by Alexander Shulgin. In his book PiHKAL, Shulgin lists the dosage as 20-30 mg and the duration as 2-4 hours. He describes 2C-B-Ind as a psychedelic with effects similar to 2C-B but with a slightly longer duration.

Pharmacology

Like other drugs in the 2C family, 2C-B-Ind is a serotonin receptor agonist. It acts primarily on the 5-HT2A receptor, which is involved in the regulation of mood, anxiety, and perception. The drug's effects are thought to be due to its action on this receptor.

Effects

The effects of 2C-B-Ind are similar to those of other psychedelic drugs. Users report visual hallucinations, enhanced sensory perception, and altered states of consciousness. The drug is also reported to have entactogenic effects, such as increased empathy and feelings of closeness with others.

Legal status

The legal status of 2C-B-Ind varies by country. In the United States, it is a Schedule I controlled substance. In the United Kingdom, it is a Class A drug.

See also

• 2C-B
• 2C-I
• 2C-E
• 2C-T-2
• 2C-T-7
• 2C-P

2CB-Ind Resources
Latest articles Most recent articles Ongoing trials	Wikipedia